title: Spontaneous abortion in a Danish population-based cohort of childhood cancer survivors.
abstract: OBJECTIVE
  Radiation induces germ-cell mutations in experimental animals that result in adverse pregnancy outcomes, as does uterine damage caused by high-dose radiotherapy. We assessed the risks for spontaneous abortion and stillbirths among cancer survivors who received radiotherapy and subsequently became pregnant.
  
  
  METHODS
  We identified 1,688 female survivors of childhood cancer in the Danish Cancer Registry. Radiation doses to the ovary and uterus were characterized as high to low. The pregnancy outcomes of survivors, 2,737 sisters, and 16,700 comparison women in the population were identified from nationwide registries. The proportions of pregnancies among survivors that resulted in a livebirth, stillbirth, or abortion were compared with the equivalent proportions among the two comparison groups, and proportion ratios (PRs) were computed with sisters as referent.
  
  
  RESULTS
  More than 34,000 pregnancies were evaluated, 1,479 of which were among cancer survivors. No significant differences were seen between survivors and comparison women in the proportions of livebirths, stillbirths, or all types of abortions combined. Survivors, however, had a 23% excess risk for spontaneous abortion (PR, 1.23; 95% CI, 1.0 to 1.5), related primarily to prior radiation treatments (PR, 1.58; 95% CI, 1.2 to 2.2) and especially high-dose radiotherapy to the ovaries and uterus (PR, 2.8; 95% CI, 1.7 to 4.7).
  
  
  CONCLUSIONS
  The pregnancy outcomes of survivors were similar to those of comparison women. A slight excess risk for spontaneous abortion may have resulted from uterine damage after high-dose pelvic radiotherapy, consistent with previous studies, although radiation-induced germinal mutations or decreased hypothalamic-pituitary-ovarian function could not be ruled out.
authors.affiliation: Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark; jeanette@cancer.dk.
authors.forename: Jeanette F
authors.initials: JF
authors.lastname: Winther
authors.forename: John D
authors.initials: JD
authors.lastname: Boice
authors.forename: Anne Louise
authors.initials: AL
authors.lastname: Svendsen
authors.forename: Kirsten
authors.initials: K
authors.lastname: Frederiksen
authors.forename: Marilyn
authors.initials: M
authors.lastname: Stovall
authors.forename: Jørgen H
authors.initials: JH
authors.lastname: Olsen
mesh_terms: D000022:Abortion, Spontaneous / Q000453:epidemiology*; D015331:Cohort Studies; D003718:Denmark / Q000453:epidemiology; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology*; D010053:Ovary / Q000528:radiation effects; D010388:Pelvis / Q000528:radiation effects; D011247:Pregnancy; D011256:Pregnancy Outcome; D017741:Survivors; D014599:Uterus / Q000528:radiation effects
references.citation: Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1364-8
references.pmid: 15050311
references.citation: Int J Cancer. 1989 Mar 15;43(3):399-402
references.pmid: 2538400
references.citation: Psychooncology. 2003 Apr-May;12(3):213-25
references.pmid: 12673806
references.citation: Am J Hum Genet. 2004 Jun;74(6):1282-5
references.pmid: 15106125
references.citation: Cancer. 1982 Jun 1;49(11):2285-8
references.pmid: 6280837
references.citation: Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):542-52
references.pmid: 15380591
references.citation: Psychooncology. 2004 Oct;13(10):689-99
references.pmid: 15386645
references.citation: Semin Reprod Med. 2006 Feb;24(1):33-9
references.pmid: 16418976
references.citation: Cancer. 1999 Aug 15;86(4):697-709
references.pmid: 10440699
references.citation: J Clin Endocrinol Metab. 2003 Nov;88(11):5307-14
references.pmid: 14602766
references.citation: N Engl J Med. 1998 May 7;338(19):1339-44
references.pmid: 9571253
references.citation: J Clin Endocrinol Metab. 1989 Oct;69(4):804-12
references.pmid: 2506214
references.citation: Hum Reprod. 2001 Sep;16(9):1838-44
references.pmid: 11527885
references.citation: Dan Med Bull. 1999 Jun;46(3):263-8
references.pmid: 10421985
references.citation: Dan Med Bull. 1997 Nov;44(5):535-9
references.pmid: 9408738
references.citation: Br J Obstet Gynaecol. 1992 May;99(5):392-4
references.pmid: 1622911
references.citation: Health Phys. 2003 Jul;85(1):65-80
references.pmid: 12852473
references.citation: J Natl Cancer Inst. 2006 Oct 18;98(20):1453-61
references.pmid: 17047194
references.citation: Int J Cancer. 1987 Nov 15;40(5):620-4
references.pmid: 3679589
references.citation: Br J Cancer. 2003 Feb 10;88(3):382-7
references.pmid: 12569380
references.citation: Nat Clin Pract Oncol. 2004 Nov;1(1):26-31
references.pmid: 16264796
references.citation: Eur J Cancer. 2007 Sep;43(13):1890-4
references.pmid: 17689068
references.citation: Am J Obstet Gynecol. 2002 Oct;187(4):1070-80
references.pmid: 12389007
references.citation: JAMA. 1987 Jan 9;257(2):216-9
references.pmid: 3025465